Neuropore Therapies
Pre-clinicalDevelops small molecule therapeutics targeting protein misfolding and aggregation for neurodegenerative diseases.
Founded
2005
Focus
Small Molecules
About
Develops small molecule therapeutics targeting protein misfolding and aggregation for neurodegenerative diseases.
Funding History
2Total raised: $30.5M
Grant$500KMichael J. Fox FoundationSep 15, 2022
Series B$30MMPM CapitalMar 15, 2021
Company Info
TypePrivate
Founded2005
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile